The North America stents market size surpassed USD 2.7 billion in 2020 and is predicted to expand at over 0.3% CAGR from 2021 to 2027 driven by growing prevalence of coronary artery diseases and rising demand for percutaneous coronary intervention procedures.

North America Stents Market Size, Share - Forecasts 2027

North America Stents Market Size By Type (Self-expandable Stents, Balloon-expandable Stents), By Material (Metal, Polymer), By Product (Vascular Stents {Coronary Stents [Bare Metal Stents, Drug Eluting Stents, Bioresorbable Stents, Peripheral Stents [Iliac, Femoral-popliteal, Renal, Carotid], Neurovascular Stents}, Non-Vascular Stents), By End-use (Hospital, Ambulatory Surgical Centers), Research Report, Regional Landscape (U.S., Canada), Growth Prospects, Competitive Industry Share & Forecasts, 2021 - 2027

Report Content

Chapter 1.&nbsp; Methodology

1.1. Definition and forecast parameters

1.1.1.&nbsp; Definitions

1.1.2.&nbsp; Methodology and forecast parameters&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

1.2. Data sources

1.3. References &amp; sources

1.3.1.&nbsp; Secondary

1.3.2.&nbsp; Primary

Chapter 2.&nbsp; Executive Summary

2.1. North America Stents industry summary, 2016 &ndash; 2026

2.1.1.&nbsp; Country trends

2.1.2.&nbsp; Product trends

2.1.3.&nbsp; Material trends

2.1.4.&nbsp; Type trends

2.1.5.&nbsp; End-use trends

Chapter 3.&nbsp; Industry Insights

3.1. Industry segmentation

3.2. Industry outlook, 2016 - 2027

3.3. Major factor analysis

3.3.1.&nbsp; Drivers

3.3.1.1.&nbsp; Growing cardiovascular disorders

3.3.1.2.&nbsp;&nbsp;&nbsp; Rising demand for minimally invasive procedures

3.3.1.3.&nbsp;&nbsp;&nbsp; Advancement in healthcare technology

3.3.1.4.&nbsp;&nbsp;&nbsp; Unhealthy and hectic lifestyle

3.3.1.5.&nbsp;&nbsp;&nbsp; Growing geriatric population

3.3.2. Industry pitfall and challenges

3.3.2.1. Stent failure and recall

3.3.2.2.&nbsp;&nbsp;&nbsp; Stringent regulatory approvals&nbsp;

3.4. COVID-19 impact analysis

3.5. Porter&rsquo;s analysis

3.6. Competitive review, 2020

3.7. PEST analysis

Chapter 4. North America Stents Market, By Product

4.1. Key trends in North America Stents market, by product

4.2. Vascular stents

4.2.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

4.2.2.&nbsp; Coronary stents

4.2.2.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

4.2.2.2.&nbsp; Bare metal stents

4.2.2.2.1. Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

4.2.2.3.&nbsp; Drug eluting stents

4.2.2.3.1. Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

4.2.2.4.&nbsp; Bioresorbable stents

4.2.2.4.1. Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

4.2.3.&nbsp; Peripheral stents

4.2.3.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

4.2.3.2.&nbsp; Iliac stents

4.2.3.2.1. Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

4.2.3.3.&nbsp; Femoral-popliteal stents

4.2.3.3.1. Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

4.2.3.4.&nbsp; Renal stents

4.2.3.4.1. Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

4.2.3.5.&nbsp; Carotid stents

4.2.3.5.1. Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

4.2.4.&nbsp; Neurovascular stents

4.2.4.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

4.3. Non-vascular stents

4.3.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

Chapter 5. North America Stents Market, By Material

5.1. Key trends in North America Stents market, by material

5.2. Metal

5.2.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

5.3. Polymer

5.3.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

Chapter 6. North America Stents Market, By Type

6.1. Key trends in North America Stents market, by type

6.2. Self-expandable stents

6.2.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

6.3. Balloon expandable stents

6.3.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

Chapter 7. North America Stents Market, By End-use

7.1. Key trends in North America Stents market, by material

7.2. Hospitals

7.2.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

7.3. Ambulatory surgical centers

7.3.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

7.4. Others

7.4.1.&nbsp; Market estimates and forecast, by country, 2016 &ndash; 2027 (USD Million &amp; Units)

Chapter 8. North America Stents Market, By Country

8.1. Key trends in North America stents market, by country

8.2. U.S.

8.2.1.&nbsp;&nbsp; Market estimates and forecast, by product, 2016 &ndash; 2027 (USD Million &amp; Units)

8.2.1.1.&nbsp; Market estimates and forecast, by vascular stents, 2016 &ndash; 2027 (USD Million &amp; Units)

8.2.1.1.1. Market estimates and forecast, by coronary stents, 2016 &ndash; 2027 (USD Million &amp; Units)

8.2.1.1.2. Market estimates and forecast, by peripheral stents, 2016 &ndash; 2027 (USD Million &amp; Units)

8.2.1.2.&nbsp; Market estimates and forecast, by material, 2016 &ndash; 2027 (USD Million &amp; Units)

8.2.1.3.&nbsp; Market estimates and forecast, by type, 2016 &ndash; 2027 (USD Million &amp; Units)

8.2.1.4.&nbsp; Market estimates and forecast, by end-use, 2016 &ndash; 2027 (USD Million &amp; Units)

8.3. Canada

8.3.1.&nbsp;&nbsp; Market estimates and forecast, by product, 2016 &ndash; 2027 (USD Million &amp; Units)

8.3.1.1.&nbsp; Market estimates and forecast, by vascular stents, 2016 &ndash; 2027 (USD Million &amp; Units)

8.3.1.1.1. Market estimates and forecast, by coronary stents, 2016 &ndash; 2027 (USD Million &amp; Units)

8.3.1.1.2. Market estimates and forecast, by peripheral stents, 2016 &ndash; 2027 (USD Million &amp; Units)

8.3.1.2.&nbsp; Market estimates and forecast, by material, 2016 &ndash; 2027 (USD Million &amp; Units)

8.3.1.3.&nbsp; Market estimates and forecast, by type, 2016 &ndash; 2027 (USD Million &amp; Units)

8.3.1.4.&nbsp; Market estimates and forecast, by end-use, 2016 &ndash; 2027 (USD Million &amp; Units)

Chapter 9.&nbsp; Company Profiles

9.1. Abbott Laboratories

9.1.1.&nbsp;&nbsp; Business overview

9.1.2.&nbsp; Financial data

9.1.3.&nbsp; Product landscape

9.1.4.&nbsp; Strategic outlook

9.2. B. Braun Melsungen AG

9.2.1.&nbsp;&nbsp; Business overview

9.2.2.&nbsp; Financial data

9.2.3.&nbsp; Product landscape

9.2.4.&nbsp; Strategic outlook

9.3. Biosensors International Group

9.3.1.&nbsp;&nbsp; Business overview

9.3.2.&nbsp; Financial data

9.3.3.&nbsp; Product landscape

9.3.4.&nbsp; Strategic outlook

9.4. Biotronik SE &amp; Co. KG

9.4.1.&nbsp;&nbsp; Business overview

9.4.2.&nbsp; Financial data

9.4.3.&nbsp; Product landscape

9.4.4.&nbsp; Strategic outlook

9.5. Boston Scientific Corporation

9.5.1.&nbsp;&nbsp; Business overview

9.5.2.&nbsp; Financial data

9.5.3.&nbsp; Product landscape

9.5.4.&nbsp; Strategic outlook

9.6. C R Bard

9.6.1.&nbsp;&nbsp; Business overview

9.6.2.&nbsp; Financial data

9.6.3.&nbsp; Product landscape

9.6.4.&nbsp; Strategic outlook

9.7. Elixir Medical Corporation

9.7.1.&nbsp;&nbsp; Business overview

9.7.2.&nbsp; Financial data

9.7.3.&nbsp; Product landscape

9.7.4.&nbsp; Strategic outlook

9.8. Medtronic Plc

9.8.1.&nbsp;&nbsp; Business overview

9.8.2.&nbsp; Financial data

9.8.3.&nbsp; Product landscape

9.8.4.&nbsp; Strategic outlook

9.9. Meril Life Science

9.9.1.&nbsp;&nbsp; Business overview

9.9.2.&nbsp; Financial data

9.9.3.&nbsp; Product landscape

9.9.4.&nbsp; Strategic outlook

9.10.&nbsp;&nbsp;&nbsp; MicroPort Scientific Corporation

9.10.1. Business overview

9.10.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial data

9.10.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product landscape

9.10.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strategic outlook

9.11.&nbsp;&nbsp;&nbsp; Stryker

9.11.1. Business overview

9.11.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial data

9.11.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product landscape

9.11.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strategic outlook

9.12.&nbsp;&nbsp;&nbsp; Terumo Corporation

9.12.1. Business overview

9.12.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial data

9.12.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product landscape

9.12.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strategic outlook

9.13.&nbsp;&nbsp;&nbsp; Veryan Medical Limited

9.13.1. Business overview

9.13.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial data

9.13.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product landscape

9.13.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strategic outlook

9.14.&nbsp;&nbsp;&nbsp; W.L Gore &amp; Associates

9.14.1. Business overview

9.14.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial data

9.14.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product landscape

9.14.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strategic outlook

&nbsp;

&nbsp;

Request sample

Contact us

Need Help ?

Get In Touch

Address

Contact

Phone :

Email:

Company

Information

Links